WARBURG BENEFITS

Warburg Cancer Therapy uses metabolic targeting of cancer's hard-coded chemical processes to preserve and enhance strong immune system function during the fight against cancer; improve the efficacy of chemotherapy; minimize chemo side-effects; and reduce cancer pain.

The goals and benefits to patients of the metabolic targeting of Warburg Cancer Therapy protocols fall broadly into six categories:

· Preservation of the health of the immune system as a result of the short duration of the immune system's exposure to toxic chemotherapy drugs under Warburg method treatment protocols.

· Enhanced immune system response efficacy as a result of unmasking cancer cells by shutting down fermentation / lactic acid production.

· Systemic immune system benefits as a the result of the creation of "natural vaccine" antigens through rapid cancer-cell die-off.

· Reduction of cancer pain as a result of the rapid reduction in the size of cancerous tumors, minimizing dependence on morphine or other analgesics.

· Increased effectiveness of chemotherapy as a result of shutting down the cell's Multi Drug Resistant Protein Pumps — internal cellular mechanisms that vastly reduce the efficacy of cancer drugs — before administering the chemo payload.

· Decreased side effects of chemotherapy and better quality of life during treatment as a result of short-duration chemo dosing, and the choice of chemotherapy drugs that are rapidly eliminated from the patient's system. Observed benefits include including stronger appetite, weight gain, better sleep, increased energy and no hair loss.

© 2026 WARBURG 瓦博 CHINA / ALL RIGHTS RESERVED

ABOUT WARBURG

Modern Warburg Metabolically Targeted Cancer Immunotherapy builds upon the work of Dr Otto Warburg, a 20th century German biochemist and physiologist. Warburg was nominated for the Nobel Prize in Medicine 47 times, and won it in 1931.

His work in the latter 1920's focused on the metabolic processes within cancer cells, specifically their method for harvesting energy and how that process could be manipulated using insulin.

His discoveries about cancer cell metabolism are the foundation for the PET-CT scan, universally acknowledged as the most accurate cancer imaging diagnostic technology available today, as well as much of our current understanding of the biochemical processes within cancer cells.

Warburg China's metabolically targeted immunotherapy method is based upon the work of Dr Tom Tsang, Dr Linda Meade-Tollin and Michael Pennington of the University of Arizona, co-inventors of our protocols.

The method combines Warburg's metabolic discoveries with a fundamental inversion of the cancer chemotherapy dosing paradigm: insulin-enabled dosing protocols which are designed to preserve the immune system and enable it to respond vigorously to cancer wherever it may be found in the body.

© 2026 WARBURG 瓦博 CHINA / ALL RIGHTS RESERVED

CONTACT WARBURG

Elements

i = 0;

while (!deck.isInOrder()) {
    print 'Iteration ' + i;
    deck.shuffle();
    i++;
}

print 'It took ' + i + ' iterations to sort the deck.';